Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Apadenoson

Next Previous
X
Search
Drug Profile

Apadenoson

Alternative Names: ATL 146e; BMS 068645; Stedivaze

Latest Information Update: 24 Oct 2021

Price :

$50 *

Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator University of Virginia
  • Developer Adenosine Therapeutics; Forest Laboratories
  • Class Alkynes; Contrast media; Purine nucleosides; Small molecules
  • Mechanism of Action Adenosine A2 receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Suspended Coronary disorders
  • Discontinued Coronary artery restenosis; Inflammation; Inflammatory bowel diseases; Reperfusion injury; Septic shock; Spinal cord injuries

Most Recent Events

  • 01 Jul 2014 Forest Laboratories has been acquired by Actavis Inc
  • 31 Dec 2012 Adenosine Therapeutics reacquires an exclusive worldwide licence to apadenoson
  • 30 Apr 2012 Suspended - Phase-III for Coronary disorders (diagnosis) in Argentina (IV)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top